ARVN (STOCKS)
Arvinas, Inc
$12.940000
-0.500000 (-3.72%)
Prev close: $13.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John G. Houston
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $831.06M
- Employees
- 430
- P/E (TTM)
- -16.74
- P/B (TTM)
- 1.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
9
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.48 | $-0.81 | +0.3298 | +40.73% |
|
Jun 2025 (Q2)
|
$-0.84 | $-1.02 | +0.1847 | +18.02% |
|
Mar 2025 (Q1)
|
$1.14 | $-0.97 | +2.1054 | +218.09% |
|
Dec 2024 (Q4)
|
$-0.63 | $-1.04 | +0.4122 | +39.55% |
Financial Statements
| Assets | $844.30M |
| Current Assets | $826.30M |
| Noncurrent Assets | $18.00M |
| Fixed Assets | $5.40M |
| Other Non-current Assets | $12.60M |
| Liabilities | $279.90M |
| Current Liabilities | $144.90M |
| Accounts Payable | $18.00M |
| Wages | $12.90M |
| Other Current Liabilities | $114.00M |
| Noncurrent Liabilities | $135.00M |
| Long-term Debt | $600.00K |
| Other Non-current Liabilities | $134.40M |
| Equity | $564.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $564.40M |
| Liabilities And Equity | $844.30M |